Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy

NCT06161922 · clinicaltrials.gov ↗

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer

Sponsor

Fudan University